Evonik expands operations to maintain solid growth

Chemical giant Evonik reported a solid performance despite a tough market in 2013.

Financial data showed that the German group generated 12.9 billion euros ($17.78 billion) in sales last year. The figure is projected to rise slightly in 2014.

The macroeconomic situation was tougher than anticipated in 2013. Evonik's customer industries and business performance were affected by the low economic growth in Asia-Pacific and North America, which are important regions for the company.